Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 16Neoplasms 3Neoplasm Metastasis 2Multiple Endocrine Neoplasia Type 1 1Hormone Receptor Positive Advanced Breast Cancer 1HR+ Breast Cancer 1HER2-positive Metastatic Breast Cancer 1Breast Neoplasm Female 1Breast Diseases 1Breast Cancer Organoids 1

Interventions

abemaciclib 2Blood Specimen Collection 2ribociclib 1palbociclib 1Watchful Waiting 1Surgical Procedures, Operative 1Letrozole 1Lead 1High-Energy Shock Waves 1Genotype 1Fulvestrant 1Bone Density 1Body Height 1Blood Pressure 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Diseases × Fulvestrant × Clear all
NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

The Affiliated Hospital of Qingdao University

Not yet recruiting
200 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡